Exploring Quality of Life and Cost in Myelodysplastic Syndromes

This chapter explores how red blood cell transfusions affect the quality of life for patients with myelodysplastic syndromes, focusing on the roles of frailty and comorbidities. It also discusses recent research on frailty scores, hospitalization rates, and the financial implications of care in Canada versus other countries, highlighting the necessity of understanding these factors for better treatment policies.